Cyclodextrin and KR12-Lipopeptide Interactions
Natural antimicrobial peptides are a promising new class of antibiotics that offer a potential response to the growing challenge of
NO-releasing cyclodextrins
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
Mannose with anti-cancer effect
In a recently published Nature report it was investigated how tumor cells respond to different forms of sugar [1]. It
Self-decontaminating biocatalyst against nerve gases
Chemical warfare agents (CWA) are one of the most brutal weapons created by mankind [1]. CWAs are inexpensive and are
Cyclodextrins involved in clinical trials to start
According to clinicaltrials.gov, currently, there are 14 cyclodextrin-related clinical trials that in the status of i) Not yet recruiting, ii)
Biodegradable antibacterial multilayer on polylactic acid-based food packaging
Polylactic acid (PLLA) was internally blended with zinc oxide nanoparticles and chitosan and carboxyethyl BCD (CEBCD) layers were deposited by
Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression
If approved, ZULRESSO would be the first medicine specifically indicated for the treatment of postpartum depression (PPD) Sage Therapeutics (NASDAQ:
Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP
Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, announced positive
HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
Mallinckrodt Pharmaceuticals recently revealed findings of their completed registration trial for VTS-270 (Hydroxypropyl Betadex- HPBCD), a development product to treat
New Clinical Trial for Efficacy and Safety of Sugammadex in 0-2 Years Old Children
Federal Research Institute of Pediatric Hematology, Oncology and Immunology is about to launch a clinical study at Dmitry Rogachev National
Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
A recently published patent application of Cell and Molecular Tissue Engineering LLC (WO2017180708) discloses a method of lowering the concentrations of